List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. A Low-Swap Powered Air Purifying Respirator (PAPR)

    SBC: CREARE LLC            Topic: CBD181002

    Creare has developed compact, high-efficiency blowers and comfortable, low-leakage closures for chem-bio protective gear that will enabledevelopment of a powered air purifying respirator (PAPR) with a high protection factor and low size, weight, and power consumption (SWaP).Our system will provide higher protection factors than conventional PAPR technology and be much more comfortable to wear than ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. A uMECS miniature blower for respiratory protection systems, Phase II

    SBC: Vibrant Composites Inc.            Topic: CBD14103

    Air management solutions capable of reducing heat and moisture burden are not suitable for integration in wearable respiratory protection systems due to excessive weight, volume, and power requirements of existing technologies. Vibrant Composites proposes applying its unique uMECS manufacturing technology towards development of an ultra-lightweight and power efficient miniature blower. Fundamental ...

    SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense
  3. AOTF LWIR Hyperspectral Imager

    SBC: DRS SCIENTIFIC INC            Topic: CBD13104

    Under a Phase II program, DRS Scientific will build, test, and deliver a new type of Acousto-Optic Tuned Filter (AOTF) hyperspectral imager that is compact, rugged, and inexpensive, has no moving parts, and is fast and sensitive. It will cover 8-12 micron wavelength range with 10 wavenumber spectral resolution or finer, and will have micro-Flick sensitivity with a cooled camera, and

    SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense
  4. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Given the unforeseen/unanticipated use of nerve agents in the battlefield and on the homeland, military personnel can benefit from this oncedaily pretreatment. It may also be desirable to pretreat certain medical and emergency aid personnel following a known/suspected nerveagent attack. Also, a novel, improved PB extended release formulations can be commercialized for the treatment of myasthenia g ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  5. Burkholderia antibody molecules for therapeutics and diagnostics

    SBC: BIOO SCIENTIFIC CORPORATION            Topic: CBD14105

    Burkholderia pseudomallei and Burkholderia mallei are highly pathogenic Gram - negative bacteria and the causative agents of melioidosis and glanders, respectively. These infections, which occur in humans and other animals, are endemic is wide regions of the developing world. This Phase II SBIR project will build on the success of our Phase I work, which established methods for generating monoclon ...

    SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense
  6. Chemical Warfare Agent (CWA) Lightweight Field-Portable (Hand-Held) Medical Diagnostic Tool

    SBC: RAPID PATHOGEN SCREENING, INC.            Topic: CBD06104

    Various methods and techniques have been developed in the laboratory for the detection and identification of exposure to chemical warfare nerve agents (CWNAs). A broad range of analytical methods is available to screen urine, blood or body tissues for traces of CWNAs or their breakdown products. Laboratory-based methods allow the differentiation between CWNAs and non-CWNAs that are used in agric ...

    SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense
  7. Chemical Warfare Agent (CWA) Lightweight Field-Portable (Hand-Held) Medical Diagnostic Tool

    SBC: SEMOREX, INC.            Topic: CBD06104

    Chemical weapon nerve agents (CWNAs) are extremely deadly substances, and as a key element in the arsenals of rogue nations and terrorists who are willing to use them, they represent a constant threat to our military and civilian personnel. Current methods for detecting CWNA exposure in individuals have many deficiencies, including excessive false-positives (triggered by pesticides) and false-neg ...

    SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense
  8. Computer-Assisted Strain Construction And Development Engineering (CASCADE)

    SBC: GENOMATICA, INC.            Topic: CBD06107

    The recent advances of modern high-throughput genomic technologies have resulted in a large number of fully sequenced microbial organisms. The construction of these comprehensive metabolic models serves many purposes including encapsulating all the data and allowing for in silco experiments to be performed that can drive experimental work and aid in strain development and optimization. The creatio ...

    SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense
  9. Computer-Assisted Strain Construction And Development Engineering (CASCADE)

    SBC: QUANTUM INTELLIGENCE, INC.            Topic: CBD06107

    This proposal aims at solving for a “Computer-Assisted Strain Construction and Development Engineering (CASCADE)” (SBIR CBD06-107). Our approach is to integrate BioSpice (a DOD product) and our statistical model developed by Quantum Intelligence together with publicly available data to develop a system for discovering the predictive relations between genomic fingerprints of an organism and it ...

    SBIR Phase I 2006 Department of DefenseOffice for Chemical and Biological Defense
  10. Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions

    SBC: Carrera Bioscience Inc.            Topic: CBD152004

    Modern metagenomics studies on diverse microbiomes revealed immense repertoires of potential natural products/antibiotics to be tapped into.However, identifying such secondary metabolites (SMs) directly from a complex microbiome remains rarely successful due to two major technicalchallenges: i) difficulty in dissecting complex microbiome samples and massive metagenomics data, and ii) difficulty in ...

    SBIR Phase I 2015 Department of DefenseOffice for Chemical and Biological Defense

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government